FDA Advisory Panel Recommends Emergency Authorization Of COVID-19 Antiviral

The New York Times (11/30, Robbins, Zimmer) reports the FDA’s Antimicrobial Drugs Advisory Committee, “in a surprisingly narrow 13-to-10 vote, endorsed” Merck & Co.’s oral COVID-19 antiviral therapy molnupiravir, which now “could be authorized for use in...